18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vascular clamping in liver surgery: physiology, indications and techniques

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This article reviews the historical evolution of hepatic vascular clamping and their indications. The anatomic basis for partial and complete vascular clamping will be discussed, as will the rationales of continuous and intermittent vascular clamping.

          Specific techniques discussed and described include inflow clamping (Pringle maneuver, extra-hepatic selective clamping and intraglissonian clamping) and outflow clamping (total vascular exclusion, hepatic vascular exclusion with preservation of caval flow). The fundamental role of a low Central Venous Pressure during open and laparoscopic hepatectomy is described, as is the difference in their intra-operative measurements. The biological basis for ischemic preconditioning will be elucidated. Although the potential dangers of vascular clamping and the development of modern coagulation devices question the need for systemic clamping; the pre-operative factors and unforseen intra-operative events that mandate the use of hepatic vascular clamping will be highlighted.

          Related collections

          Most cited references76

          • Record: found
          • Abstract: found
          • Article: not found

          The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.

          To standardize the definition of postoperative liver failure (PLF) for prediction of early mortality after hepatectomy. The definition of PLF is not standardized, making the comparison of innovations in surgical techniques and the timely use of specific therapeutic interventions complex. Between 1998 and 2002, 775 elective liver resections, including 69% for malignancies and 60% major resections, were included in a prospective database. The nontumorous liver was abnormal in 43% with steatosis >30% in 14%, noncirrhotic fibrosis in 43%, and cirrhosis in 12%. The impact of prothrombin time (PT) 50 micromol/L on postoperative days (POD) 1, 3, 5, and 7 was analyzed. The lowest PT level was observed on postoperative day (POD) 1, while the peak of SB was observed on POD 3. These 2 variables tended to return to preoperative values by POD 5. The median interval between hepatectomy and postoperative death was 15 days (range, 5-39 days). Postoperative mortality significantly increased in patients with PT 50 microml/L. The conjunction of PT 50 micromol/L on POD 5 was a strong predictive factor of mortality. In patients with significant morbidity, this "50-50 criteria" was met 3 to 8 days before clinical evidence of complications. The association of PT 50 microml/L on POD 5 (the 50-50 criteria) was a simple, early, and accurate predictor of more than 50% mortality rate after hepatectomy. This criteria could be identified early enough, before clinical evidence of complications, for specific interventions to be applied in due time.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Extended resections for hilar cholangiocarcinoma.

            To evaluate different strategies for extended resections of hilar cholangiocarcinomas on radicality and survival. Surgical resection of hilar cholangiocarcinoma is the only potentially curative treatment. Resection of central bile duct carcinomas, however, cannot always comply with the general principles of surgical oncology to achieve wide tumor-free margins with no-touch techniques. From 1988 to 1998, 95 patients underwent resection of hilar cholangiocarcinoma. Eighty patients had hilar and hepatic resections and 15 had liver transplantation and partial pancreatoduodenectomy (LTPP; i.e., eradication of the entire biliary tract using a no-touch technique). The 60-day death rate was 8%. The overall 1- and 5-year survival rates were 67% and 22%, respectively. Five-year survival rates after R0, R1, and R2 resections were 37%, 9%, and 0%. In a multivariate analysis, surgical radicality was the strongest determinant of survival (p < 0.001). The rate of formally curative resection (R0 resection) was significantly lower in hilar resections (29%) than in liver resections (left hemihepatectomy 59%, right hemihepatectomy 55%, right trisegmentectomy 65%; p < 0.05). The highest rate of R0 resection was observed after LTPP (93%; p < 0.05). Right trisegmentectomies achieved the highest rate of 5-year survival after R0 resection (57%). In a multivariate analysis of patient survival after R0 resection, additional portal vein resection was the only significant factor. The 5-year survival rate after formally curative liver resection with portal vein resection was 65% versus 28% without. Extended resections, especially right trisegmentectomies and LTPP, resulted in the highest rate of R0 resection. Right trisegmentectomy together with portal vein resection best represents the principles of surgical oncology and may be regarded as the surgical procedure of choice. Immunosuppression limits the applicability of LTPP.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma.

                Bookmark

                Author and article information

                Journal
                Ann Surg Innov Res
                Annals of Surgical Innovation and Research
                BioMed Central
                1750-1164
                2010
                26 March 2010
                : 4
                : 2
                Affiliations
                [1 ]Department of Surgery, Centre Hospitalier Intercommunal, Poissy, France
                [2 ]Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
                [3 ]Digestive Surgery Department, Hôpital Henri Mondor - University Paris-XII, Créteil, France
                Article
                1750-1164-4-2
                10.1186/1750-1164-4-2
                2857838
                20346153
                8746489c-7af9-4198-8eb1-ccc30fb4e43e
                Copyright ©2010 Chouillard et al; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 December 2009
                : 26 March 2010
                Categories
                Review

                Surgery
                Surgery

                Comments

                Comment on this article